The expression of common prostate cancer biomarkers, including AR, AMACR, PSA, PSMA, ERG, and neuroendocrine markers (synaptophysin, chromogranin A and CD56) were continually assessed across PDX generations. This evidence concerns the gene AR and Familial prostate cancer.